» Articles » PMID: 8731004

A Likelihood Approach to Meta-analysis with Random Effects

Overview
Journal Stat Med
Publisher Wiley
Specialty Public Health
Date 1996 Mar 30
PMID 8731004
Citations 122
Authors
Affiliations
Soon will be listed here.
Abstract

In a meta-analysis of a set of clinical trials, a crucial but problematic component is providing an estimate and confidence interval for the overall treatment effect theta. Since in the presence of heterogeneity a fixed effect approach yields an artificially narrow confidence interval for theta, the random effects method of DerSimonian and Laird, which incorporates a moment estimator of the between-trial components of variance sigma B2, has been advocated. With the additional distributional assumptions of normality, a confidence interval for theta may be obtained. However, this method does not provide a confidence interval for sigma B2, nor a confidence interval for theta which takes account of the fact that sigma B2 has to be estimated from the data. We show how a likelihood based method can be used to overcome these problems, and use profile likelihoods to construct likelihood based confidence intervals. This approach yields an appropriately widened confidence interval compared with the standard random effects method. Examples of application to a published meta-analysis and a multicentre clinical trial are discussed. It is concluded that likelihood based methods are preferred to the standard method in undertaking random effects meta-analysis when the value of sigma B2 has an important effect on the overall estimated treatment effect.

Citing Articles

Two-Arm Crossover Randomized Controlled Trial Versus Meta-Analysis of N-of-1 Studies: Comparison of Statistical Efficiency in Determining an Intervention Effect.

Carrozzo A, Zimmermann G, Bathke A, Neunhaeuserer D, Niebauer J, Kulnik S Biom J. 2025; 67(2):e70045.

PMID: 40071868 PMC: 11898578. DOI: 10.1002/bimj.70045.


Mortality of Acute Kidney Injury in Cirrhosis: A Systematic Review and Meta-Analysis of Over 5 Million Patients Across Different Clinical Settings.

Lekakis V, Wong F, Gkoufa A, Papatheodoridis G, Cholongitas E Aliment Pharmacol Ther. 2024; 61(3):420-432.

PMID: 39641300 PMC: 11707646. DOI: 10.1111/apt.18426.


Impact of pre-transplant malignancy on outcomes in kidney transplant recipients: an updated meta-analysis with systematic review.

Zhang H, Hu X World J Urol. 2024; 43(1):5.

PMID: 39621141 DOI: 10.1007/s00345-024-05376-5.


Temperature, Crime, and Violence: A Systematic Review and Meta-Analysis.

Choi H, Heo S, Foo D, Song Y, Stewart R, Son J Environ Health Perspect. 2024; 132(10):106001.

PMID: 39404825 PMC: 11477092. DOI: 10.1289/EHP14300.


Second Primary Malignancies after CAR T-Cell Therapy: A Systematic Review and Meta-analysis of 5,517 Lymphoma and Myeloma Patients.

Tix T, Alhomoud M, Shouval R, Cliff E, Perales M, Cordas Dos Santos D Clin Cancer Res. 2024; 30(20):4690-4700.

PMID: 39256908 PMC: 11546643. DOI: 10.1158/1078-0432.CCR-24-1798.